These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 38470)

  • 21. Advantages and disadvantages of depot-neuroleptics as maintenance medication for chronic schizophrenics.
    Möller HJ; Kissling W
    Clin Neuropharmacol; 1986; 9 Suppl 4():259-62. PubMed ID: 2882841
    [No Abstract]   [Full Text] [Related]  

  • 22. Lowest effective dose of depot neuroleptics.
    Hoencamp E; Haffmans PJ; Jansen GS
    Br J Psychiatry; 1992 Mar; 160():422-3. PubMed ID: 1348655
    [No Abstract]   [Full Text] [Related]  

  • 23. Antipsychotic drug doses in a schizophrenia inpatient unit.
    Galletly CA
    Aust N Z J Psychiatry; 1992 Dec; 26(4):574-6. PubMed ID: 1362051
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Self-reported prescribing practices for schizophrenic patients among Israeli psychiatrists.
    Heresco-Levy U; Brom D; Greenberg D
    Isr J Psychiatry Relat Sci; 1993; 30(3):164-74. PubMed ID: 7901179
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Pharmaco-epidemiological study on antipsychotic drug prescription in French Psychiatry: Patient characteristics, antipsychotic treatment, and care management for schizophrenia].
    Brunot A; Lachaux B; Sontag H; Casadebaig F; Philippe A; Rouillon F; Cléry-Melin P; Hergueta T; Llorca PM; Moreaudefarges T; Guillon P; Lebrun T
    Encephale; 2002; 28(2):129-38. PubMed ID: 11972139
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oral antipsychotic update: a brief review of new and investigational agents for the treatment of schizophrenia.
    Citrome L
    CNS Spectr; 2012 Nov; 17 Suppl 1():1-9. PubMed ID: 23448847
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A pharmacoeconomic model of outpatient antipsychotic therapy in "revolving door" schizophrenic patients.
    Glazer WM; Ereshefsky L
    J Clin Psychiatry; 1996 Aug; 57(8):337-45. PubMed ID: 8752015
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Long-term treatment of outpatients with depot neuroleptics (author's transl)].
    Saameli W
    Schweiz Rundsch Med Prax; 1981 Feb; 70(6):206-10. PubMed ID: 6113584
    [No Abstract]   [Full Text] [Related]  

  • 29. [Is depot formulation a long-term optimal treatment option?].
    Musch A
    Med Monatsschr Pharm; 2005 Nov; 28(11):414-6. PubMed ID: 16309031
    [No Abstract]   [Full Text] [Related]  

  • 30. Depot fluphenazine decanoate and enanthate for schizophrenia.
    David A; Adams CE; Eisenbruch M; Quraishi S; Rathbone J
    Cochrane Database Syst Rev; 2005 Jan; (1):CD000307. PubMed ID: 15674872
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Results of a survey on the use of delayed-action neuroleptics in psychiatry].
    Bourin M; Venisse JL; Lecuyer F
    Encephale; 1990; 16(5):363-9. PubMed ID: 1979942
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Psychological aspects of depot treatment of schizophrenic syndromes].
    Jacobsson L; Odling H
    Lakartidningen; 1980 Oct; 77(40):3522-6. PubMed ID: 6109045
    [No Abstract]   [Full Text] [Related]  

  • 33. Impace of depot neuroleptics on psychiatry.
    Corbett L
    Minn Med; 1979 Feb; 62(2):97-100. PubMed ID: 34788
    [No Abstract]   [Full Text] [Related]  

  • 34. Standard and long-acting depot neuroleptics in chronic schizophrenics: an 18-month open multicentric study.
    Simon P; Fermanian J; Ginestet D; Goujet MA; Péron-Magnan P
    Arch Gen Psychiatry; 1978 Jul; 35(7):893-7. PubMed ID: 28102
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [5 years' experience with prolonged-action neuroleptics].
    Lopez-Ibor Aliño JM; Tabares Pujante J
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1973; 1(5):721-31. PubMed ID: 4150175
    [No Abstract]   [Full Text] [Related]  

  • 36. Acute schizophrenia.
    Johnstone EC
    Br J Hosp Med; 1985 Oct; 34(4):198-201. PubMed ID: 2868766
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Depot neuroleptics: a comparative review of standard, intermediate, and low-dose regimens.
    Kane JM; Woerner M; Sarantakos S
    J Clin Psychiatry; 1986 May; 47 Suppl():30-3. PubMed ID: 2871014
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Depot bromperidol decanoate for schizophrenia.
    Wong D; Adams CE; David A; Quraishi SN
    Cochrane Database Syst Rev; 2004; (3):CD001719. PubMed ID: 15266450
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neuroleptics, subjective perception and quality of life.
    Eranti S; Chaturvedi SK
    Acta Psychiatr Scand; 1998 Aug; 98(2):165-6. PubMed ID: 9718244
    [No Abstract]   [Full Text] [Related]  

  • 40. Treatment of late-life schizophrenia with neuroleptics.
    Jeste DV; Lacro JP; Gilbert PL; Kline J; Kline N
    Schizophr Bull; 1993; 19(4):817-30. PubMed ID: 7905663
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.